{
    "id": 1089,
    "fullName": "ARAF S214F",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "ARAF S214F does not lie within any known functional domains of the Araf protein (UniProt.org). S214F confers a gain of function to the Araf protein as indicated by enhanced Mek phosphorylation, colony formation (PMID: 24569458), cell proliferation and viability in culture (PMID: 29533785), tumor formation in animal models, and confers resistance to Egfr inhibitors in culture (PMID: 27478040).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 251,
                    "pubMedId": 24569458,
                    "title": "Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24569458"
                },
                {
                    "id": 11238,
                    "pubMedId": 29533785,
                    "title": "Systematic Functional Annotation of Somatic Mutations in Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29533785"
                },
                {
                    "id": 8124,
                    "pubMedId": 27478040,
                    "title": "High-throughput Phenotyping of Lung Cancer Somatic Mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27478040"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 369,
        "geneSymbol": "ARAF",
        "terms": [
            "ARAF",
            "A-RAF",
            "ARAF1",
            "PKS2",
            "RAFA1"
        ]
    },
    "variant": "S214F",
    "createDate": "07/22/2014",
    "updateDate": "08/23/2018",
    "referenceTranscriptCoordinates": {
        "id": 90716,
        "transcript": "NM_001654",
        "gDna": "chrX:g.47566722C>T",
        "cDna": "c.641C>T",
        "protein": "p.S214F",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 2325,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Nexavar (sorafenib) inhibited growth of transformed lung epithelial cells expressing ARAF S214F in culture (PMID: 24569458).",
            "molecularProfile": {
                "id": 1129,
                "profileName": "ARAF S214F"
            },
            "therapy": {
                "id": 920,
                "therapyName": "Sorafenib",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 251,
                    "pubMedId": 24569458,
                    "title": "Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24569458"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8084,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Mekinist (trametinib) reduced Erk phosphorylation and inhibited growth of transformed lung epithelial cells expressing ARAF S214F in culture (PMID: 24569458).",
            "molecularProfile": {
                "id": 1129,
                "profileName": "ARAF S214F"
            },
            "therapy": {
                "id": 2,
                "therapyName": "Trametinib",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 251,
                    "pubMedId": 24569458,
                    "title": "Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24569458"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 1129,
            "profileName": "ARAF S214F",
            "profileTreatmentApproaches": [
                {
                    "id": 4395,
                    "name": "RAF Inhibitor (Pan)",
                    "profileName": "ARAF S214F"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 90716,
            "transcript": "NM_001654",
            "gDna": "chrX:g.47566722C>T",
            "cDna": "c.641C>T",
            "protein": "p.S214F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 90717,
            "transcript": "XM_011543908",
            "gDna": "chrX:g.47566722C>T",
            "cDna": "c.641C>T",
            "protein": "p.S214F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}